Status:
UNKNOWN
Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity
Lead Sponsor:
Assiut University
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
Rheumatoid arthritis (RA) is an autoimmune disease in which a symmetrical Synovial inflammation, bone destruction occur in both small and big Joints. If left untreated, this illness does not generally...
Eligibility Criteria
Inclusion
- Patients age is \> 20 years old.
- All rheumatoid arthritis patients must fulfill the 2010 ACR/EULAR criteria for RA.
Exclusion
- Patients age is \< 20 years old.
- Patient with evidence of any concomitant inflammatory disease, Acute infection or chronic inflammatory status.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT05422313
Start Date
June 1 2022
End Date
December 1 2023
Last Update
June 22 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.